HomeCompoundbibliothekenFDA-approved & Passed Phase I Drug Library

FDA-approved & Passed Phase I Drug Library

Cat.Nr.L3800

Een unieke collectie van 4200 geneesmiddelen die wereldwijd op de markt zijn of klinische fase 1 hebben doorstaan en gebruikt kunnen worden voor high throughput screening (HTS) en high content screening (HCS).

96 well plates

Stel uw bibliotheek samen:

Geciteerd door 335 Publicaties

FDA-approved & Passed Phase I Drug Library Inhoud

Beschrijving & Voordelen

• A unique collection of 4200 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)

•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development

• Safety confirmed by clinical phase 1

• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc

• Structurally diverse, medicinally active, and cell permeable.

• Rich documentation with structure, IC50, and customer reviews

• NMR and HPLC validated to ensure the highest purity

Productdetails

Formulering 3768 compounds pre-dissolved in 10mM DMSO, 301 compounds pre-dissolved in 10mM water, 110 compounds pre-dissolved in 2mM DMSO, 19 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO
Container 96 Deep Well Plate verzegeld met aluminiumfolie
Stabiliteit 12 months -20°C in DMSO
24 months -80°C in DMSO
Verzending Blauw ijs of droog ijs

Casestudies met Selleck Compound Libraries

FDA-approved & Passed Phase I Drug Library Samenstelling

HTS Faciliteit Partners

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania